Persistent fetal vasculature (PFV) is a congenital anomaly caused due to incomplete regression of the hyaloidal fetal vasculature. [1] [2] [3] Fig. 1a shows a Mitterndorf dot -a circular opacity on the posterior lens capsule, nasal to the center, which represents the anterior attachment of the hyaloid artery. Fig. 1b shows limited anterior PFV obscuring the visual axis with a classical stalk. Fig. 1c demonstrates PFV presenting with a vascularized membrane and prominent ciliary processes. Fig. 1d images the remnant posterior end of the stalk, the Bergmeister papilla. Identification of these clinical signs enables correct diagnosis and management of PFV.
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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. CRM is rare congenital anomaly and consists of aberrant branch of a retinal vessel crossing the macula and horizontal raphe. [1] Commonly, CRM is a vein, but it may arise from an artery as well and is uusually asymptomatic.
[1] Visual loss in patients with CRM has been attributed to serous detachment, [2] macro aneurysm, [3] branch retinal artery occlusion, [4] macular haemorrhage, vitreous haemorrhage, [5] foveal cyst, or mere presence of blood vessel.
[1] FFA in CRM usually reveals early filling and delayed emptying and may be associated with dilated capillary bed surrounding the vessels. [6] CRM has never been reported in patient with RRD. The association of the two appears to be coincidental though.
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